OPKO HEALTH INC (OPK)
US68375N1037 - Common Stock
ChartMill assigns a Buy % Consensus number of 86% to OPK. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.34. This target is 252.44% above the current price.
OPK was analyzed by 10 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about OPK.
In the previous month the buy percentage consensus was at a similar level.
OPK was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-04-03 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2024-04-01 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-04-01 | Piper Sandler | Reiterate | Overweight -> Overweight |
| 2024-02-28 | Barrington Research | Maintains | Outperform -> Outperform |
| 2024-02-28 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-08-07 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-06-29 | Barrington Research | Upgrade | Market Perform -> Outperform |
| 2023-05-05 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-03-09 | HC Wainwright & Co. | Reiterate | Buy |
| 2023-02-24 | HC Wainwright & Co. | Reiterate | Buy |
| 2022-12-15 | HC Wainwright & Co. | Initiate | Buy |
| 2022-08-05 | Piper Sandler | Maintains | Overweight |
| 2022-05-10 | Piper Sandler | Maintains | Overweight |
| 2022-01-24 | Barrington Research | Downgrade | Outperform -> Market Perform |
| 2021-06-21 | Ladenburg Thalmann | Initiate | Buy |